Topical Coconut Oil Contributes to Systemic Monolaurin Levels in Very Preterm Infants

Neonatology. 2019;116(3):299-301. doi: 10.1159/000501280. Epub 2019 Jul 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / blood*
  • Candida albicans / drug effects
  • Candida albicans / growth & development
  • Coconut Oil / administration & dosage
  • Coconut Oil / metabolism*
  • Female
  • Gestational Age
  • Humans
  • Infant, Extremely Premature*
  • Infant, Newborn
  • Laurates / administration & dosage
  • Laurates / blood*
  • Male
  • Monoglycerides / administration & dosage
  • Monoglycerides / blood*
  • Neonatal Sepsis / microbiology
  • Neonatal Sepsis / prevention & control
  • Premature Birth*
  • Randomized Controlled Trials as Topic
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / growth & development
  • Staphylococcus epidermidis / drug effects
  • Staphylococcus epidermidis / growth & development

Substances

  • Anti-Infective Agents
  • Laurates
  • Monoglycerides
  • monolaurin
  • Coconut Oil